Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
124
NCT04112433
Novel Cardiac Signal Processing System
Phase: N/A
Role: Lead Sponsor
Start: Nov 12, 2019
Completion: Jan 29, 2022
NCT04964440
Redo AF Sub Study (of the Pure EP 2.0 Main Study)
Start: Mar 3, 2021